Sign up USA
Proactive Investors - Run By Investors For Investors

Q BioMed says cancer pain drug will be available later this month

The Strontium Chloride 89 (SR89) injection has been approved by the FDA ..
Q BioMed says cancer pain drug will be available later this month
A cancer cell

Q BioMed Inc (OTCMKTS:QBIO)  said it expects its cancer pain drug to be available later this month (October) and announced the launch of a website for  patients, doctors and caregivers.

The Strontium Chloride 89 (SR89) injection has been approved by the FDA and is a non-opioid injection to relieve bone pain in patients with painful skeletal metastases.

Clinical studies showed the combination of alternating weekly chemohormonal therapies with Strontium-89 demonstrated a prolonged progression-free and overall survival in patients.

The website is at  http://www.PainFreeCancer.com.

In the body, Strontium-89 acts in a similar way to calcium and is preferentially taken up in osteoblastic tissue selectively localizing in bone.

Q BioMed shares added 2.13% to US$3.83 each.

View full QBIO profile View Profile

Q BioMed Inc Timeline

Related Articles

1-Operation.jpg
January 18 2017
Deltex’s overseas sales are booming but its previously dominant NHS revenues are dropping off
man at a micrscope
September 29 2017
The company is a specialist in the storage of stems cells from the umbilical cord, which could provide a potentially life-saving treatment for 82 blood-borne diseases
the word antioxidant
August 15 2017
The heparin test is the firm’s lead product; however the company’s OxiChek device for oxidative stress is also gaining traction
Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use